NCT02583009View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea

PHASE2CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

August 31, 2016

Conditions
Rosacea
Interventions
DRUG

PAC-14028 cream 0.1%

Topical application

DRUG

PAC-14028 cream 0.3%

Topical application

DRUG

PAC-14028 cream 1.0%

Topical application

DRUG

PAC-14028 cream vehicle

Topical application

Trial Locations (1)

Unknown

Korea University Ansan Hospital, Ansan-si

All Listed Sponsors
lead

Amorepacific Corporation

INDUSTRY

NCT02583009 - A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea | Biotech Hunter | Biotech Hunter